Matt O'Brien's Stock Ratings

Piper Sandler Analyst

Matt O'Brien is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/28/2024

Overall Average Return

-3.70%

Smart Score

52.9%

Overall Average Return Percentile

30th

Number of Ratings

100
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
04/25/2024CNMDBuy Now
Conmed
$65.7844.42%Piper Sandler
Matt O'Brien52%
$100 → $95MaintainsOverweightGet Alert
04/03/2024PENBuy Now
Penumbra
$204.4141.87%Piper Sandler
Matt O'Brien52%
$290 → $290ReiteratesOverweight → OverweightGet Alert
03/28/2024TMDXBuy Now
TransMedics Gr
$92.802.37%Piper Sandler
Matt O'Brien52%
 → $95Initiates → OverweightGet Alert
03/28/2024SIBNBuy Now
SI-BONE
$14.5771.59%Piper Sandler
Matt O'Brien52%
 → $25Initiates → OverweightGet Alert
03/27/2024FNABuy Now
Paragon 28
$8.80104.55%Piper Sandler
Matt O'Brien52%
 → $18MaintainsOverweightGet Alert
03/22/2024TELABuy Now
TELA Bio
$4.45169.66%Piper Sandler
Matt O'Brien52%
$15 → $12MaintainsOverweightGet Alert
02/27/2024STAABuy Now
Staar Surgical
$46.96-29.73%Piper Sandler
Matt O'Brien52%
$40 → $33MaintainsNeutralGet Alert
02/23/2024RCELBuy Now
AVITA Medical
$8.52146.48%Piper Sandler
Matt O'Brien52%
$19 → $21ReiteratesOverweight → OverweightGet Alert
02/23/2024PENBuy Now
Penumbra
$204.4141.87%Piper Sandler
Matt O'Brien52%
$310 → $290ReiteratesOverweight → OverweightGet Alert
02/23/2024PODDBuy Now
Insulet
$163.5040.67%Piper Sandler
Matt O'Brien52%
$250 → $230MaintainsOverweightGet Alert
02/01/2024CNMDBuy Now
Conmed
$65.7852.02%Piper Sandler
Matt O'Brien52%
$130 → $100MaintainsOverweightGet Alert
01/26/2024CVRXBuy Now
CVRx
$14.69124.64%Piper Sandler
Matt O'Brien52%
$21 → $33MaintainsOverweightGet Alert
12/22/2023GKOSBuy Now
Glaukos
$99.485.55%Piper Sandler
Matt O'Brien52%
$90 → $105MaintainsOverweightGet Alert
12/19/2023DXCMBuy Now
DexCom
$124.2020.77%Piper Sandler
Matt O'Brien52%
$135 → $150MaintainsOverweightGet Alert
11/10/2023HUMABuy Now
Humacyte
$3.95-24.06%Piper Sandler
Matt O'Brien52%
$3.5 → $3MaintainsNeutralGet Alert
11/10/2023RCELBuy Now
AVITA Medical
$8.52123%Piper Sandler
Matt O'Brien52%
$23 → $19MaintainsOverweightGet Alert
11/09/2023CUTRBuy Now
Cutera
$2.1241.52%Piper Sandler
Matt O'Brien52%
$18 → $3MaintainsNeutralGet Alert
11/06/2023TFXBuy Now
Teleflex
$206.718.85%Piper Sandler
Matt O'Brien52%
$210 → $225MaintainsNeutralGet Alert
11/03/2023PENBuy Now
Penumbra
$204.4122.3%Piper Sandler
Matt O'Brien52%
$335 → $250MaintainsOverweightGet Alert